/

Immunomodulators and Biologics in Dermatologic Treatment Turning Theory into Practice

Bhatia, Neal
Innbundet / 2024 / Engelsk

Produktdetaljer

ISBN
9783031665899
Publisert
2024-09-22
Utgiver
Vendor
Springer International Publishing AG
Høyde
235 mm
Bredde
155 mm
Aldersnivå
Professional/practitioner, P, 06
Språk
Product language
Engelsk
Format
Product format
Innbundet

Redaktør
Bhatia, Neal

Om bidragsyterne

Dr. Neal Bhatia is a leading dermatologist in Southern California with extensive experience in treating a wide range of common and rare dermatological diseases.  After earning dual bachelor of science degrees in bacteriology and genetics from the University of Wisconsin, Dr. Bhatia completed his medical degree at the University of Wisconsin School of Medicine before completing residencies in internal medicine and dermatology at Medical College of Wisconsin in Milwaukee.  He serves as Director of Clinical Dermatology at Therapeutics Clinical Research and is Chief Medical Editor for the journal Practical Dermatology.  He has a background in immunology and has interests in mechanisms of therapy, skin cancer, and medical dermatology.  He has been involved in countless clinical trials as well.  Dr. Bhatia has served on the AAD Board of Directors as well as Vice President of the AAD in 2021, and he maintains memberships in several other professional organizations.

 

 

Immunomodulators and Biologics in Dermatologic Treatment Turning Theory into Practice

Bhatia, Neal
Innbundet / 2024 / Engelsk
Bhatia, Neal
Innbundet / 2024 / Engelsk
Nettpris:
1.611,-
Levering 7-20 dager
Sjekk lagerstatus i butikk
This title provides a practically applicable guide to the use of immunomodulators and biologics to treat cutaneous diseases. Chapters cover the mechanisms, applications and safety concerns pertaining to the latest systemic therapies. Extensive guidance is provided on how to design lab monitoring schedules, manage patient follow-up visits, develop tapering plans and assess adverse outcomes. The book also reviews how to initiate off-label applications and establish methods of matching mechanisms for a range of diseases to the mechanisms of the available therapies. The latest updates in the development and utility of systemic immunomodulators, biologics and JAK Inhibitors from clinical trials and updated guidelines are also discussed. Immunomodulators and Biologics in Dermatologic Treatment comprehensively describes the use of a range of systemic therapies for immunomodulation in dermatology and how best to incorporate these into practice. It therefore represents a valuable resource for novice readers and experienced dermatologists involved in the management of these patients.  
Les mer
Introduction.- Mechanisms of Action: Targets for Immunomodulators.- Steroid and Non-Steroid Immunomodulators.- Biologics as Immunomodulators.- Combinations of topical and systemic Immunomodulators,- Nanotechnology and Immunomodulators.- Antibiotics and Antimicrobials as Immunomodulators.- Integrative Therapies as Immunomodulators.- Immunomodulators and Biologics for Follicular and Neutrophilic Cutaneous Disorders.- Immunomodulators for Common Dermatologic Disorders.- Prescribing and Advocating for Immunomodulators in Dermatology Practice.- Conclusion.
Les mer
This title provides a practically applicable guide to the use of immunomodulators and biologics to treat cutaneous diseases. Chapters cover the mechanisms, applications and safety concerns pertaining to the latest systemic therapies. Extensive guidance is provided on how to design lab monitoring schedules, manage patient follow-up visits, develop tapering plans and assess adverse outcomes. The book also reviews how to initiate off-label applications and establish methods of matching mechanisms for a range of diseases to the mechanisms of the available therapies. The latest updates in the development and utility of systemic immunomodulators, biologics and JAK Inhibitors from clinical trials and updated guidelines are also discussed. Immunomodulators and Biologics in Dermatologic Treatment comprehensively describes the use of a range of systemic therapies for immunomodulation in dermatology and how best to incorporate these into practice. It therefore represents a valuable resource for novice readers and experienced dermatologists involved in the management of these patients.  
Les mer
Provides the clinical building blocks for all physicians involved in managing these patients Contains comprehensive coverage of the topic from the basic science through to management options Features extensive guidance on establishing best practice for the use of immunomodulators and biologics
Les mer
GPSR Compliance The European Union's (EU) General Product Safety Regulation (GPSR) is a set of rules that requires consumer products to be safe and our obligations to ensure this. If you have any concerns about our products you can contact us on ProductSafety@springernature.com. In case Publisher is established outside the EU, the EU authorized representative is: Springer Nature Customer Service Center GmbH Europaplatz 3 69115 Heidelberg, Germany ProductSafety@springernature.com
Les mer

Relaterte produkter

This title provides a practically applicable guide to the use of immunomodulators and biologics to treat cutaneous diseases. Chapters cover the mechanisms, applications and safety concerns pertaining to the latest systemic therapies. Extensive guidance is provided on how to design lab monitoring schedules, manage patient follow-up visits, develop tapering plans and assess adverse outcomes. The book also reviews how to initiate off-label applications and establish methods of matching mechanisms for a range of diseases to the mechanisms of the available therapies. The latest updates in the development and utility of systemic immunomodulators, biologics and JAK Inhibitors from clinical trials and updated guidelines are also discussed. Immunomodulators and Biologics in Dermatologic Treatment comprehensively describes the use of a range of systemic therapies for immunomodulation in dermatology and how best to incorporate these into practice. It therefore represents a valuable resource for novice readers and experienced dermatologists involved in the management of these patients.  
Les mer
Introduction.- Mechanisms of Action: Targets for Immunomodulators.- Steroid and Non-Steroid Immunomodulators.- Biologics as Immunomodulators.- Combinations of topical and systemic Immunomodulators,- Nanotechnology and Immunomodulators.- Antibiotics and Antimicrobials as Immunomodulators.- Integrative Therapies as Immunomodulators.- Immunomodulators and Biologics for Follicular and Neutrophilic Cutaneous Disorders.- Immunomodulators for Common Dermatologic Disorders.- Prescribing and Advocating for Immunomodulators in Dermatology Practice.- Conclusion.
Les mer
This title provides a practically applicable guide to the use of immunomodulators and biologics to treat cutaneous diseases. Chapters cover the mechanisms, applications and safety concerns pertaining to the latest systemic therapies. Extensive guidance is provided on how to design lab monitoring schedules, manage patient follow-up visits, develop tapering plans and assess adverse outcomes. The book also reviews how to initiate off-label applications and establish methods of matching mechanisms for a range of diseases to the mechanisms of the available therapies. The latest updates in the development and utility of systemic immunomodulators, biologics and JAK Inhibitors from clinical trials and updated guidelines are also discussed. Immunomodulators and Biologics in Dermatologic Treatment comprehensively describes the use of a range of systemic therapies for immunomodulation in dermatology and how best to incorporate these into practice. It therefore represents a valuable resource for novice readers and experienced dermatologists involved in the management of these patients.  
Les mer
Provides the clinical building blocks for all physicians involved in managing these patients Contains comprehensive coverage of the topic from the basic science through to management options Features extensive guidance on establishing best practice for the use of immunomodulators and biologics
Les mer
GPSR Compliance The European Union's (EU) General Product Safety Regulation (GPSR) is a set of rules that requires consumer products to be safe and our obligations to ensure this. If you have any concerns about our products you can contact us on ProductSafety@springernature.com. In case Publisher is established outside the EU, the EU authorized representative is: Springer Nature Customer Service Center GmbH Europaplatz 3 69115 Heidelberg, Germany ProductSafety@springernature.com
Les mer

Produktdetaljer

ISBN
9783031665899
Publisert
2024-09-22
Utgiver
Vendor
Springer International Publishing AG
Høyde
235 mm
Bredde
155 mm
Aldersnivå
Professional/practitioner, P, 06
Språk
Product language
Engelsk
Format
Product format
Innbundet

Redaktør
Bhatia, Neal

Om bidragsyterne

Dr. Neal Bhatia is a leading dermatologist in Southern California with extensive experience in treating a wide range of common and rare dermatological diseases.  After earning dual bachelor of science degrees in bacteriology and genetics from the University of Wisconsin, Dr. Bhatia completed his medical degree at the University of Wisconsin School of Medicine before completing residencies in internal medicine and dermatology at Medical College of Wisconsin in Milwaukee.  He serves as Director of Clinical Dermatology at Therapeutics Clinical Research and is Chief Medical Editor for the journal Practical Dermatology.  He has a background in immunology and has interests in mechanisms of therapy, skin cancer, and medical dermatology.  He has been involved in countless clinical trials as well.  Dr. Bhatia has served on the AAD Board of Directors as well as Vice President of the AAD in 2021, and he maintains memberships in several other professional organizations.

 

 

Relaterte produkter